Skip to main content
SpringerLink
Log in

Primary Liver Cancer: Radiation Therapy Planning

  • Chapter
  • First Online:
Book cover Radiation Therapy for Gastrointestinal Cancers

  • 1183 Accesses

Abstract

The development of modern radiotherapy planning and delivery techniques has enabled safe and effective delivery of tumoricidal doses of liver-directed radiotherapy. With more refined assessments of hepatotoxicity risk, an increasing number of patients with primary liver cancer have received liver-directed radiotherapy, including patients who were not candidates for curative treatments such as surgical resection or orthotopic liver transplantation. In this chapter, we discuss radiotherapy planning and delivery techniques for primary liver cancers. We also discuss supporting evidence for the use of liver-directed radiotherapy in both hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lo SS, Fakiris AJ, Chang EL, et al. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol. Jan 2010;7(1):44–54.

    Article  PubMed  Google Scholar 

  2. Hong TS, Bosch WR, Krishnan S, et al. Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines. Int J Radiat Oncol Biol Phys. 2014;89(4):804–13.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Araki T, Itai Y, Furui S, Tasaka A. Dynamic CT densitometry of hepatic tumors. AJR Am J Roentgenol. 1980;135(5):1037–43.

    Article  CAS  PubMed  Google Scholar 

  4. Baron RL, Oliver 3rd JH, Dodd 3rd GD, Nalesnik M, Holbert BL, Carr B. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology. 1996;199(2):505–11.

    Article  CAS  PubMed  Google Scholar 

  5. Kanematsu M, Semelka RC, Leonardou P, Mastropasqua M, Lee JK. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. J Magn Reson Imaging (JMRI). 2003;18(2):189–95.

    Article  Google Scholar 

  6. Honda H, Tajima T, Kajiyama K, et al. Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings. AJR Am J Roentgenol. 1999;173(5):1213–7.

    Article  CAS  PubMed  Google Scholar 

  7. Niska J, Keane FK, Wolfgang J, et al. Impact of IV contrast enhancement phase on target definition for Hepatocellular Carcinoma(HCC) and Intrahepatic Cholangiocarcinoma(IHC): observations from patients enrolled on a prospective phase II trial. Pract Radiat Oncol. 2015; (In press).

    Google Scholar 

  8. Rummeny E, Weissleder R, Stark DD, et al. Primary liver tumors: diagnosis by MR imaging. AJR Am J Roentgenol. Jan 1989;152(1):63–72.

    Article  CAS  PubMed  Google Scholar 

  9. Yamashita Y, Hatanaka Y, Yamamoto H, et al. Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging. Radiology. 1994;193(1):59–65.

    Article  CAS  PubMed  Google Scholar 

  10. Kim TK, Choi BI, Han JK, Jang HJ, Cho SG, Han MC. Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings. Radiology. 1997;204(2):539–43.

    Article  CAS  PubMed  Google Scholar 

  11. Iavarone M, Piscaglia F, Vavassori S, et al. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. J Hepatol. 2013;58(6):1188–93.

    Article  PubMed  Google Scholar 

  12. Valls C, Guma A, Puig I, et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging. 2000;25(5):490–6.

    Article  CAS  PubMed  Google Scholar 

  13. Miura F, Okazumi S, Takayama W, et al. Hemodynamics of intrahepatic cholangiocarcinoma: evaluation with single-level dynamic CT during hepatic arteriography. Abdom Imaging. 2004;29(4):467–71.

    Article  CAS  PubMed  Google Scholar 

  14. Kim SA, Lee JM, Lee KB, et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology. 2011;260(1):148–57.

    Article  PubMed  Google Scholar 

  15. Lee JM, Zech CJ, Bolondi L, et al. Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging. Korean J Radiol. 2011;12(4):403–15.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Heinzerling JH, Anderson JF, Papiez L, et al. Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. Int J Radiat Oncol Biol Phys. 2008;70(5):1571–8.

    Article  PubMed  Google Scholar 

  17. Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol. 1994;33(6):677–83.

    Article  CAS  PubMed  Google Scholar 

  18. Langen KM, Jones DT. Organ motion and its management. Int J Radiat Oncol Biol Phys. 2001;50(1):265–78.

    Article  CAS  PubMed  Google Scholar 

  19. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 1995;34(6):861–70.

    Article  CAS  PubMed  Google Scholar 

  20. Tse RV, Hawkins M, Lockwood G, et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol. 2008;26(4):657–64.

    Article  PubMed  Google Scholar 

  21. Wong JW, Sharpe MB, Jaffray DA, et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys. 1999;44(4):911–9.

    Article  CAS  PubMed  Google Scholar 

  22. Eccles C, Brock KK, Bissonnette JP, Hawkins M, Dawson LA. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2006;64(3):751–9.

    Article  PubMed  Google Scholar 

  23. Dawson LA, Eccles C, Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol. 2006;45(7):856–64.

    Article  PubMed  Google Scholar 

  24. Dawson LA, Brock KK, Kazanjian S, et al. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys. 2001;51(5):1410–21.

    Article  CAS  PubMed  Google Scholar 

  25. Hong TS, DeLaney TF, Mamon HJ, et al. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. Pract Radiat Oncol. 2014;4(5):316–22.

    Article  PubMed  Google Scholar 

  26. Case RB, Sonke JJ, Moseley DJ, Kim J, Brock KK, Dawson LA. Inter- and intrafraction variability in liver position in non-breath-hold stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2009;75(1):302–8.

    Article  PubMed  Google Scholar 

  27. Eccles CL, Patel R, Simeonov AK, Lockwood G, Haider M, Dawson LA. Comparison of liver tumor motion with and without abdominal compression using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2011;79(2):602–8.

    Article  PubMed  Google Scholar 

  28. Dawson LA, Ten Haken RK, Lawrence TS. Partial irradiation of the liver. Semin Radiat Oncol. Jul 2001;11(3):240–6.

    Article  CAS  PubMed  Google Scholar 

  29. Eccles CL, Dawson LA, Moseley JL, Brock KK. Interfraction liver shape variability and impact on GTV position during liver stereotactic radiotherapy using abdominal compression. Int J Radiat Oncol Biol Phys. 2011;80(3):938–46.

    Article  PubMed  Google Scholar 

  30. Dawson LA, Ten Haken RK. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol. 2005;15(4):279–83.

    Article  PubMed  Google Scholar 

  31. Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med. 1965;93:200–8.

    CAS  PubMed  Google Scholar 

  32. Russell AH, Clyde C, Wasserman TH, Turner SS, Rotman M. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys. 1993;27(1):117–23.

    Article  CAS  PubMed  Google Scholar 

  33. Ben-Josef E, Normolle D, Ensminger WD, et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2005;23(34):8739–47.

    Article  PubMed  Google Scholar 

  34. Jung J, Yoon SM, Kim SY, et al. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters. Radiat Oncol. 2013;8:249.

    Article  PubMed  PubMed Central  Google Scholar 

  35. McGinn CJ, Ten Haken RK, Ensminger WD, Walker S, Wang S, Lawrence TS. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol. Jun 1998;16(6):2246–52.

    CAS  PubMed  Google Scholar 

  36. Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2000;18(11):2210–8.

    CAS  PubMed  Google Scholar 

  37. Bujold A, Massey CA, Kim JJ, et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol. 2013;31(13):1631–9.

    Article  PubMed  Google Scholar 

  38. Clinicaltrials.gov identifier NCT01730937. Accessed 30 Sept 2015.

  39. Yoon SS, Aloia TA, Haynes AB, et al. Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy. Pract Radiat Oncol. 2014;4(3):167–73.

    Article  PubMed  Google Scholar 

  40. Nakayama H, Sugahara S, Tokita M, et al. Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. Cancer. 2009;115(23):5499–506.

    Article  PubMed  Google Scholar 

  41. Hong TS, Wo JY, Beow YY, et al. A multi-institutional phase II study of high dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol. 2015; (In press)

    Google Scholar 

  42. Clinicaltrials.gov identifier NCT02200042. Accessed 31 Mar 2016.

  43. Jang WI, Kim MS, Bae SH, et al. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma. Radiat Oncol. 2013;8:250.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Tao R, Krishnan S, Bhosale PR, et al. Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis. J Clin Oncol. 2016;34(3):219–26.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Florence K. Keane MD & Theodore Hong MD

Authors
  1. Florence K. Keane MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theodore Hong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Theodore Hong MD .

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Theodore Hong

  2. The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Prajnan Das

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Keane, F.K., Hong, T. (2017). Primary Liver Cancer: Radiation Therapy Planning. In: Hong, T., Das, P. (eds) Radiation Therapy for Gastrointestinal Cancers. Springer, Cham. https://doi.org/10.1007/978-3-319-43115-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43115-4_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43113-0

  • Online ISBN: 978-3-319-43115-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation